14 | July 2022 HEALTH
Study Available For Adults Living With Someone Recently Diagnosed With COVID-19 By Stacy M. Brown NNPA Newswire Senior National Correspondent
I
n the third year of the COVID-19 pandemic, there continues to be a surge of cases in parts of the United States. Many of these cases may occur when people catch the virus in their communities and bring it home, where it can spread to other members of their household. Some doctors are currently enrolling individuals for a clinical study to determine whether an investigational oral medicine may be able to help prevent that household transmission. Clinical studies are research studies performed with volunteers that aim to evaluate if investigational treatments are safe and effective for people.
they're at higher risk of becoming "There is a continuing need to infected and continuing the spread investigate new therapies to due to their close proximity to help reduce the risk of spreading these individuals for extended COVID-19," said Dr. Fabian periods of time." Sandoval, president & CEO of Unvaccinated adults living with someone who is sympthe Emerson Clinical Research tomatic and recently tested positive for COVID-19 Institute. "In particular, we need to may be able to enroll in a clinical study, called MOVefocus on people living with SARS- AHEAD, which is evaluating an investigational oral medicine to help prevent COVID-19 infection CoV-2-infected individuals because antiviral within households.
The MOVe-AHEAD clinical study is being conducted at over 50 sites across the U.S. To take part in the study, individuals must be 18 years or older and cannot have confirmed or suspected COVID-19. Individuals are not eligible to participate if they have received a COVID-19 vaccine or have previously had laboratory-confirmed SARS-CoV-2 infection. Additionally, potential study participants must live with an adult or child who: * Tested positive for COVID-19 in the last five days; and * Currently has at least one symptom of COVID-19, such as fever or difficulty breathing
For a household to qualify for the study, there can be only one household member with symptoms of COVID-19 and a positive test. Other criteria apply. Once accepted, participants will be in the study for up to 35 days and have six visits to the clinic, with one of the visits being virtual by telephone. Those enrolled in the study will receive study-related care at no cost and may receive reimbursement for study-related time and travel. "Through this clinical study, people have an opportunity to potentially help uncover new medicines that may help prevent COVID-19 transmission." For more information on this clinical study, visit CovidMoveAhead.com. This sponsored article is presented by Merck.
Experience Our World of Advertising, Marketing, Media and Communication
Source: BPT
